The Effect of Green Tea Extract on Type 2 Diabetes With Hyperlipidemia

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 102 participants.

Also called NCT01360567

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 102 participants (enrolled count) (from the registry)
Sponsor
Taipei City Hospital (from the registry)
Registry
  • NCT NCT01360567
Other papers using this trial's data
  • Effects of green tea extract on insulin resistance and glucagon-like peptide 1 in patients with type 2 diabetes and lipid abnormalities: a randomized, double-blinded, and placebo-controlled trial PloS one, 2014 DOI, PubMed 24614112, PMC3948786 In the PMC Open Access subset under CC BY.

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Taiwan (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01360567. Randomized; double masking; primary purpose treatment. Start 2011-05 (registry gives no type); primary completion 2012-11 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Effect of Green Tea Extract on Type 2 Diabetes With Hyperlipidemia
Condition
Hyperlipidemia
Intervention (Dietary supplement)
Green tea extract
Intervention (Dietary supplement)
Placebo
Lead sponsor
Taipei City Hospital (class: other government)
Collaborator
National Yang Ming Chiao Tung University (class: other)

Record details

Record id
cardio:ct-nct01360567
Content hash
dde2f42df0485b885f7b321424ebe2b704cdfc0ba4dafd59e6debbe2e61718e1